PDCD1 and cancer: These intricate interactions often involve immune checkpoint pathways such as programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1), creating a dynamic battleground in which cancer and the immune system engage in an ongoing struggle.16